https://www.selleckchem.com/pr....oducts/NVP-AUY922.ht
(MicroVention, Tustin, CA, USA). Participants assigned to a coil embolization cohort will undergo traditional endovascular coiling. The primary endpoint will be complete occlusion confirmed by cerebral angiography at 12 months after treatment. Secondary safety outcomes will evaluate periprocedural and post-procedural complications for up to 12 months. The trial will begin enrollment in 2022, and clinical data will be available after enrollment and follow-up. This article describes the aim and design of a multi-center, randomized, ope
Like
Comment
Share
